Acidic Solution Virus Release for AAV Manufacturing
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for producing non-enveloped viruses, such as adeno-associated viruses, face challenges in achieving high purity and efficiency without laborious operations, particularly in the steps preceding purification.
Innovation Solution
A method involving culturing virus-producing cells and exposing them to an acidic solution with a pH of 3.0-6.0, containing sodium or potassium ions, which allows for the efficient release and purification of non-enveloped viruses without physical cell disruption, using techniques like ultracentrifugation, chromatography, or ultrafiltration.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If physical cell disruption methods (ultrasonic disruption, freeze-thaw) are used to release viruses from cells, then virus release efficiency is improved, but operation complexity and laboriousness increase
Solution Approach 1:
The patent replaces mechanical physical disruption methods (ultrasonic vibration, freeze-thaw cycles) with a chemical method using acidic solution (pH 3.0-6.0) to release viruses from cell pellets. The acidic solution dissolves the cell membrane and releases viral particles through chemical action rather than mechanical force, significantly simplifying the operation while maintaining high virus release efficiency.
2Manufacturing precision
If multiple purification steps are performed to achieve high virus purity, then manufacturing precision is improved, but productivity decreases
Solution Approach 1:
The patent performs preliminary virus release directly in the acidic solution during the cell lysis step, so that virus particles are already in a dissolved and separated state before purification. This preliminary action in the acidic environment facilitates subsequent purification steps by reducing protein aggregation and improving virus solubility, thereby achieving high purity with fewer and more efficient purification steps.
3Ease of manufacture
If conventional virus production methods are used, then ease of manufacture is maintained, but virus titer and purity are insufficient
Solution Approach 1:
The patent changes the pH parameter of the solution to an acidic range (pH 3.0-6.0) during the virus release step, which fundamentally alters the chemical environment for virus extraction. This parameter change improves virus solubility, prevents protein aggregation, and enhances both virus titer and purity while maintaining ease of manufacture through a simple solution-based approach rather than complex process changes.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This method enables the efficient production of high-purity non-enveloped viruses, as demonstrated by increased genomic titer and reduced contaminating protein levels, facilitating their use in gene therapy and research applications.
Implementation Method 1
bringing the cell into contact with an acidic solution... does not comprise a physical cell disruption method
Implementation Method 2
The cell homogenate is subjected to a suitable step such as filtration with a filter, ultracentrifugation, chromatography, or ultrafiltration to purify the rAAV vectors
Implementation Method 3
The cell homogenate is subjected to a suitable step such as filtration with a filter, ultracentrifugation, chromatography, or ultrafiltration to purify the rAAV vectors
Implementation Method 4
The cell homogenate is subjected to a suitable step such as filtration with a filter, ultracentrifugation, chromatography, or ultrafiltration to purify the rAAV vectors
Data Source
Figure 1
Figure 2
Figure 3
AI summary
The present invention provides a method for efficiently manufacturing a non-enveloped virus with high purity without laborious operation by cultivating cells having the ability to produce a non-enveloped virus and bringing the cells and an acidic solution into contact with each other. A non-enveloped virus vector manufactured by the method of the present invention and a composition having the non-enveloped viral vector as an active ingredient are very useful as gene transfer methods in the fields of basic research and clinical application gene therapy.